Pharmacopeia

CWP-0092

ERYTHROMYCIN

Anti-infectives · Level 3 Gastrointestinal · Level 3

Core pharmacology

Introduction

Macrolide antibiotic

Absorption

10-60% absorption
Undergoes first pass metabolism

Distribution

Poor CSF penetration but good lung penetration

Protein binding

85% PB

Volume of distribution

Vd 0.3-1.2L/kg

Metabolism

Hepatic demethylation

Excretion

Renally excreted (15% unchanged)

Half-life

T1/2= 1.5 hours

Class Group

ANTIBIOTIC:
MACROLIDE

Presentation

Topical, oral, IV

Antimicrobial Spectrum

1. Gram positives
2. Anaerobes
Obligate intracellular organisms (legionella, mycoplasma)

Mechanism of action

Macrolide antimicrobial that binds the 50S ribosomal subunit and inhibits bacterial protein synthesis. It also acts as a motilin-receptor agonist in the stomach and duodenum, increasing lower-oesophageal sphincter tone and gastrointestinal motility.

Adverse Effects Toxicity

1. Must be avoided in porphyria 2. Nausea, vomiting, diarrhea 3. Hypersensitivity 4. QT prolongation and increased risk of torsade’s 5. Inhibits CYP3A4 (increased warfarin, carbamazepine, ciclosporin, valproate, tacrolimus, digoxin) Inhibits p-glycoprotein